Michael Gelband’s Otonomy, Inc. OTIC Stock Holding History

Michael Gelband’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,867	Closed	-$36K	–	2698
2022 Q1	$36K	Buy	+14,867	New	+$31.6K	﹤0.01%	2084
2021 Q4	–	Sell	-11,898	Closed	-$23K	–	2760
2021 Q3	$23K	Buy	+11,898	New	+$20.2K	﹤0.01%	2012
2021 Q2	–	Sell	-67,835	Closed	-$173K	–	2985
2021 Q1	$173K	Sell	67,835 -277,567	-80%	-$1.14M	﹤0.01%	1899
2020 Q4	$2.23M	Buy	+345,402	New	+$1.57M	0.02%	501

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Michael Gelband's OTIC Position: Q2 2022 in Review

Michael Gelband sold out of Otonomy, Inc. (OTIC) in Q2 2022, closing a stake of 14,867 shares — an estimated $36K sold.

Michael Gelband first reported a position in OTIC in Q4 2020 and held it in 4 quarters. The position peaked at $2.23M in Q4 2020. 50 funds tracked by Wall St. Rank hold OTIC as of Q2 2022.

Michael Gelband reported no remaining Otonomy, Inc. position as of Q2 2022 after selling out during the quarter.
Michael Gelband sold 14,867 Otonomy, Inc. shares in Q2 2022, an estimated $36K.
Michael Gelband first reported a position in Otonomy, Inc. in Q4 2020 and held it in 4 quarters.
Michael Gelband's Otonomy, Inc. position peaked at $2.23M in Q4 2020.
50 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.